These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 94908)

  • 61. Microbial ribosomal vaccines.
    Gregory RL
    Rev Infect Dis; 1986; 8(2):208-17. PubMed ID: 3518022
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Prevention of some respiratory virus diseases with aerosols. II. Effectiveness of interferon and vaccine in influenzal infection].
    Sărăţeanu D; Babes VT; Demetrescu R; Danielescu G
    Stud Cercet Inframicrobiol; 1967; 18(6):433-9. PubMed ID: 5590424
    [No Abstract]   [Full Text] [Related]  

  • 63. Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant.
    Ozaki T; Yauchi M; Xin KQ; Hirahara F; Okuda K
    Viral Immunol; 2005; 18(2):373-80. PubMed ID: 16035949
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung.
    Proudfoot O; Esparon S; Tang CK; Laurie K; Barr I; Pietersz G
    BMC Infect Dis; 2015 Feb; 15():101. PubMed ID: 25887952
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice.
    Kimoto T; Kim H; Sakai S; Takahashi E; Kido H
    Vaccine; 2019 Jan; 37(4):612-622. PubMed ID: 30553569
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice.
    Ben Ahmeida ET; Gregoriadis G; Potter CW; Jennings R
    Vaccine; 1993 Oct; 11(13):1302-9. PubMed ID: 8296483
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influenza vaccination with adjuvant RU41740 in the elderly.
    Profeta ML; Guidi G; Meroni PL; Palmieri R; Palladino G; Cantone V; Zanussi C
    Lancet; 1987 Apr; 1(8539):973. PubMed ID: 2882355
    [No Abstract]   [Full Text] [Related]  

  • 68. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.
    Tamura S; Miyata K; Matsuo K; Asanuma H; Takahashi H; Nakajima K; Suzuki Y; Aizawa C; Kurata T
    J Immunol; 1996 May; 156(10):3892-900. PubMed ID: 8621928
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The IgA and subclass IgG responses and protection in mice immunised with influenza antigens administered as ISCOMS, with FCA, ALH or as infectious virus.
    Ben Ahmeida ET; Jennings R; Erturk M; Potter CW
    Arch Virol; 1992; 125(1-4):71-86. PubMed ID: 1642561
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
    Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
    Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vaccination with cell immunoglobulin mucin-1 antibodies and inactivated influenza enhances vaccine-specific lymphocyte proliferation, interferon-gamma production and cross-strain reactivity.
    Soo Hoo W; Jensen ER; Saadat A; Nieto D; Moss RB; Carlo DJ; Moll T
    Clin Exp Immunol; 2006 Jul; 145(1):123-9. PubMed ID: 16792682
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity.
    Wang J; Li P; Yu Y; Fu Y; Jiang H; Lu M; Sun Z; Jiang S; Lu L; Wu MX
    Science; 2020 Feb; 367(6480):. PubMed ID: 32079747
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunoglobulin production in man stimulated by an orally administered bacterial lysate.
    Puigdollers JM; Serna GR; Hernandez del Rey I; Barruffet MT; Torroella JJ
    Respiration; 1980; 40(3):142-9. PubMed ID: 7003667
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae.
    Goetsch L; Gonzalez A; Plotnicky-Gilquin H; Haeuw JF; Aubry JP; Beck A; Bonnefoy JY; Corvaïa N
    Infect Immun; 2001 Oct; 69(10):6434-44. PubMed ID: 11553588
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Naturally occurring immune response against bacteria commonly involved in upper respiratory tract infections: analysis of the antigen-specific salivary IgA levels.
    Rossi GA; Peri C; Raynal ME; Defilippi AC; Risso FM; Schenone G; Pallestrini E; Melioli G
    Immunol Lett; 2003 Mar; 86(1):85-91. PubMed ID: 12600750
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity.
    Liew FY; Russell SM; Appleyard G; Brand CM; Beale J
    Eur J Immunol; 1984 Apr; 14(4):350-6. PubMed ID: 6609824
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia.
    Ichinohe T; Ainai A; Nakamura T; Akiyama Y; Maeyama J; Odagiri T; Tashiro M; Takahashi H; Sawa H; Tamura S; Chiba J; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2010 Jan; 82(1):128-37. PubMed ID: 19950232
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intranasal Inactivated Influenza Vaccines: a Reasonable Approach to Improve the Efficacy of Influenza Vaccine?
    Tamura S; Ainai A; Suzuki T; Kurata T; Hasegawa H
    Jpn J Infect Dis; 2016; 69(3):165-79. PubMed ID: 27212584
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Stimulation of specific immunologic processes by a glycoprotein factor of bacterial origin].
    Lefevre A; Gladecki K; Jardillier JC; Agneray J
    C R Acad Hebd Seances Acad Sci D; 1974 Sep; 279(13):1117-8. PubMed ID: 4219321
    [No Abstract]   [Full Text] [Related]  

  • 80. [Klebsiella pneumoniae glycoproteins as coadjuvants in the prevention of recurrent respiratory infections in children 1-6 years of age].
    Arroyave CM
    Rev Alerg Mex; 1999; 46(3):66-71. PubMed ID: 10425883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.